Nasdaq

SI-BONE (SIBN) Receives FDA Nod for Its TNT Implant System

SI-BONE, Inc. SIBN has recently received FDA 510(k) clearance for its iFuse TORQ TNT implant system ("TNT"). The TNT implant system is the first anatomy-specific system designed to meet the ...
Nasdaq

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

SANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, ...
Seeking Alpha

SI-BONE, Inc.: Small-cap Developer Of Medical Implants And A Steady Revenue Grower

SI-Bone's innovative titanium implants, including the iFuse system, address sacroiliac joint dysfunction, pelvic trauma, and spinal stability, with significant market adoption and FDA approvals.

SurGenTec Secures FDA 510(k) Clearance for TiLink™ SI joint fusion- Now Navigation Compatible

SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug ...
Seeking Alpha

Tenon Medical Announces Successful Completion of Initial Cases with New SImmetry(R)+ SI Joint Fusion System

~ SImmetry+ combines 3D-printed titanium implants, a robust joint decorticator, and a streamlined bone graft delivery system to offer treatment solutions aligned with established fusion principles ~ ~ ...